Key result
Elimination methods neutralize DOACs and heparins in diagnostic tests despite incomplete efficacy and assay interference.
Why the study?
The presence of anticoagulants or heparin contamination in samples interferes with hemostasis assessment and thrombophilia screening, necessitating methods for their removal.
Answers are grounded in this paper and cite their sources.
In vitro removal of DOACs and heparins from blood samples can improve the accuracy of hemostasis monitoring and thrombophilia screening, though current methods may have incomplete efficacy or assay interference.
The assessment of hemostasis is necessary to make suitable decisions on the management of patients with thrombotic disorders. In some clinical situations, for example, during thrombophilia screening, the presence of anticoagulants in sample makes diagnosis impossible. Various elimination methods may overcome anticoagulant interference. DOAC-Stop, DOAC-Remove and DOAC Filter are available methods to remove direct oral anticoagulants in diagnostic tests, although there are still reports on their incomplete efficacy in several assays. The new antidotes for direct oral anticoagulants - idarucizumab and andexanet alfa - could be potentially useful, but have their drawbacks. The necessity to remove heparins is also arising as heparin contamination from central venous catheter or therapy with heparin disturbs the appropriate hemostasis assessment. Heparinase and polybrene are already present in commercial reagents but a fully-effective neutralizer is still a challenge for researchers, thus promising candidates remain in the research phase.
No takes yet. Share an insight, caveat, or question.
FRACKIEWICZ et al. (2023) conducted a review in Anticoagulant interference in diagnostic tests. Anticoagulant removal methods (DOAC-Stop, DOAC-Remove, DOAC Filter, Heparinase, Polybrene) was evaluated. Various elimination methods, including DOAC-Stop, DOAC-Remove, DOAC Filter, heparinase, and polybrene, can neutralize direct oral anticoagulants and heparins in diagnostic tests, although incomplete efficacy and assay interference remain challenges.
Synapse has enriched 10 related papers. Consider them for comparative context: